Literature DB >> 25069719

Introduction of highly resistant bacteria into a hospital via patients repatriated or recently hospitalized in a foreign country.

G Birgand1, L Armand-Lefevre, M Lepainteur, I Lolom, C Neulier, F Reibel, Y Yazdanpanah, A Andremont, J C Lucet.   

Abstract

We describe the prevalence of carriage and variables associated with introduction of highly drug-resistant microorganisms (HDRMO) into a French hospital via patients repatriated or recently hospitalized in a foreign country. The prevalence of HDRMO was 11% (15/132), with nine carbapenamase-producing Enterobacteriaceae, nine carbapenem-resistant Acinetobacter baumannii and six glycopeptide-resistant enterococci. Half of the admitted patients (63/132, 48%) were colonized with extended spectrum beta-lactamase-producing Enterobacteriaceae (ESBLPE). Among the four episodes with secondary cases, three involved A. baumannii.
© 2014 The Authors Clinical Microbiology and Infection © 2014 European Society of Clinical Microbiology and Infectious Diseases.

Entities:  

Keywords:  Carbapenamase-producing Enterobacteriaceae; colonization; repatriation; vglycopeptide-resistant enterococci

Mesh:

Year:  2014        PMID: 25069719     DOI: 10.1111/1469-0691.12604

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  10 in total

1.  Universal hospital admission screening for carbapenemase-producing organisms in a low-prevalence setting.

Authors:  Jonathan A Otter; Eleonora Dyakova; Karen N Bisnauthsing; Antonio Querol-Rubiera; Amita Patel; Chioma Ahanonu; Olga Tosas Auguet; Jonathan D Edgeworth; Simon D Goldenberg
Journal:  J Antimicrob Chemother       Date:  2016-08-11       Impact factor: 5.790

2.  Control of emerging extensively drug-resistant organisms (eXDRO) in France: a survey among infection preventionists from 286 healthcare facilities.

Authors:  D Lepelletier; J C Lucet; P Astagneau; B Coignard; S Vaux; C Rabaud; B Grandbastien; P Berthelot
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-05-10       Impact factor: 3.267

3.  European hospitals as source of multidrug-resistant bacteria: analysis of travellers screened in Finland after hospitalization abroad.

Authors:  Mikael Kajova; Tamim Khawaja; Anu Kantele
Journal:  J Travel Med       Date:  2022-07-14       Impact factor: 39.194

Review 4.  Travel-acquired ESBL-producing Enterobacteriaceae: impact of colonization at individual and community level.

Authors:  Paul-Louis Woerther; Antoine Andremont; Anu Kantele
Journal:  J Travel Med       Date:  2017-04-01       Impact factor: 8.490

5.  Fast and expensive (PCR) or cheap and slow (culture)? A mathematical modelling study to explore screening for carbapenem resistance in UK hospitals.

Authors:  Gwenan M Knight; Eleonora Dyakova; Siddharth Mookerjee; Frances Davies; Eimear T Brannigan; Jonathan A Otter; Alison H Holmes
Journal:  BMC Med       Date:  2018-08-16       Impact factor: 8.775

6.  High rates of meticillin-resistant Staphylococcus aureus among asylum seekers and refugees admitted to Helsinki University Hospital, 2010 to 2017.

Authors:  Tuomas Aro; Anu Kantele
Journal:  Euro Surveill       Date:  2018-11

Review 7.  Travel-Related Antimicrobial Resistance: A Systematic Review.

Authors:  Hamid Bokhary; Krisna N A Pangesti; Harunor Rashid; Moataz Abd El Ghany; Grant A Hill-Cawthorne
Journal:  Trop Med Infect Dis       Date:  2021-01-16

8.  Mechanisms of antimicrobial resistance in Gram-negative bacilli.

Authors:  Étienne Ruppé; Paul-Louis Woerther; François Barbier
Journal:  Ann Intensive Care       Date:  2015-08-12       Impact factor: 6.925

9.  The spread of bla OXA-48 and bla OXA-244 carbapenemase genes among Klebsiella pneumoniae, Proteus mirabilis and Enterobacter spp. isolated in Moscow, Russia.

Authors:  Nadezhda K Fursova; Eugeny I Astashkin; Anastasia I Knyazeva; Nikolay N Kartsev; Ekaterina S Leonova; Olga N Ershova; Irina A Alexandrova; Natalia V Kurdyumova; Svetlana Yu Sazikina; Nikolay V Volozhantsev; Edward A Svetoch; Ivan A Dyatlov
Journal:  Ann Clin Microbiol Antimicrob       Date:  2015-11-02       Impact factor: 3.944

10.  Costs associated with implementation of a strict policy for controlling spread of highly resistant microorganisms in France.

Authors:  Gabriel Birgand; Christophe Leroy; Simone Nerome; Liem Binh Luong Nguyen; Isabelle Lolom; Laurence Armand-Lefevre; Céline Ciotti; Bertrand Lecorre; Géraldine Marcade; Vincent Fihman; Marie-Hélène Nicolas-Chanoine; Camille Pelat; Anne Perozziello; Bruno Fantin; Yazdan Yazdanpanah; Jean-Damien Ricard; Jean-Christophe Lucet
Journal:  BMJ Open       Date:  2016-01-29       Impact factor: 2.692

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.